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DObjectives: The aim of the present study was to determine the early and long-term outcomes of coronary artery
bypass grafting in patients with acute coronary syndrome and stable angina pectoris.
Methods: From September 2004 to September 2011, 382 patients with acute coronary syndrome (unstable an-
gina pectoris and non–ST-segment elevation myocardial infarction) and 851 patients with stable angina pectoris
underwent first-time isolated coronary artery bypass grafting at our institute. The early and long-term outcomes
were compared between the 2 groups.
Results: Patients with acute coronary syndrome were older, were more likely to be women, had a smaller body
surface area, and were more likely to have left main coronary artery disease. In both groups, bilateral internal
thoracic artery grafts were used in approximately 89% of the patients, and off-pump techniques in approximately
97% of the patients. The acute coronary syndrome group had a greater operative death rate (2.6% vs 0.1%) and
a greater incidence of low output syndrome (3.1% vs 1.2%) and hemodialysis requirement (2.9% vs 1.1%).
Multivariate regression analysis demonstrated that age, acute coronary syndrome, lower ejection fraction, and
higher creatinine level before surgery were independent predictors of operative death. However, among the hos-
pital survivors, no differences were seen in freedom from all death (85.4% 2.5% vs 87.7% 2.0%), cardiac
death (97.4% 0.9% vs 96.5% 0.9%), or major adverse cardiac and cerebrovascular events (78.0% 2.9%
vs 78.1%  2.3%) at 7 years between the patients with acute coronary syndrome and stable angina pectoris.
Conclusions: Although acute coronary syndrome is an independent predictor of early mortality in patients un-
dergoing coronary artery bypass grafting, the long-term outcomes after surgery were similar between patients
with acute coronary syndrome and stable angina pectoris who survived the early postoperative period. (J Thorac
Cardiovasc Surg 2013;145:1577-83)ASupplemental material is available online.
Acute coronary syndrome (ACS) is one of the leading
causes of morbidity and mortality in patients with coronary
artery disease. Technological advances have resulted in the
widespread use of percutaneous coronary intervention
(PCI), which has improved the results of ACS treatment.
In patients with ST-segment elevation myocardial infarction
(STEMI), primary PCI is recommended, if immediately
available.1 In patients with unstable angina pectoris
(UAP) or non-STEMI, either PCI or coronary artery bypass
grafting (CABG) could be recommended, depending on thee Department of Cardiovascular Surgery,a Sakakibara Heart Institute, Tokyo,
; and Department of Biostatistics and Epidemiology,b Yokohama City Uni-
y Medical Center, Yokohama, Japan.
ures: Authors have nothing to disclose with regard to commercial support.
d for publication Feb 19, 2012; revisions received April 20, 2012; accepted
blication May 16, 2012; available ahead of print June 18, 2012.
for reprints: Toshihiro Fukui, MD, Department of Cardiovascular Surgery,
ibara Heart Institute, 3-16-1 Asahi-cho, Fuchu City, Tokyo 183-0003, Japan
ail: tfukui.cvs@gmail.com).
23/$36.00
ht  2013 by The American Association for Thoracic Surgery
016/j.jtcvs.2012.05.043
The Journal of Thoracic and Carpatient characteristics and coronary lesion.2 Recent trends
in patients undergoing CABG have shown an increase in
the number of patients with left main coronary artery dis-
ease, preoperative use of the intra-aortic balloon pump,
and urgent cases,3 demonstrating that CABG remains the
treatment of choice for patients with complex coronary ar-
tery disease and high-risk factors.4
Although ACS has historically been considered a risk
factor in patients undergoing CABG, with several reports
of adverse outcomes,5 recent advances in techniques and
technology (eg, arterial grafts, off-pump CABG, and mini-
mally invasive cardiopulmonary bypass) have improved the
outcomes of patients with ACS who undergo CABG.6,7
However, few reports have evaluated the early and long-
term outcomes of patients with ACS and stable angina pec-
toris (SAP) who underwent these contemporary surgical
modalities.8,9
The aim of the present study was to compare the early and
long-term outcomes after contemporary CABG between
patients with ACS and those with SAP.
METHODS
Study Patients
From September 2004 to September 2011, 1303 patients underwent
first-time isolatedCABG at SakakibaraHeart Institute. Of these, 70 patientsdiovascular Surgery c Volume 145, Number 6 1577
Abbreviations and Acronyms
ACS ¼ acute coronary syndrome
CABG ¼ coronary artery bypass grafting
ITA ¼ internal thoracic artery
MACCE ¼ major adverse cardiac and
cerebrovascular events
PCI ¼ percutaneous coronary intervention
SAP ¼ stable angina pectoris
STEMI ¼ ST-segment elevation myocardial
infarction
UAP ¼ unstable angina pectoris
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Dwith STEMI (see Tables E1 and E2) were excluded from the present study
because the treatment strategies for patients with STEMI are complex and
differ from those for other patients. The remaining 1233 patients were
included in the present study. The preoperative characteristics of the
study patients are listed in Table 1. The preoperative diagnosis was ACS
in 382 patients (31.0%; UAP in 360 and non-STEMI in 22) and SAP in
851 patients (69.0%). Myocardial infarction was diagnosed from the elec-
trocardiographic findings and serumcardiac enzyme levels, and the location
of culprit lesion was confirmed using coronary angiography.
Patients with ACS were initially treated with aspirin, b-blockers, and
antithrombin therapy. All patients with ACS underwent angiography early
after the start of medication. After angiography, primary PCI was per-
formed when the coronary artery disease was suitable for PCI. Even if
the patients had triple-vessel disease, only the culprit lesion was treated
with PCI, when possible. Those patients underwent staged CABG after pri-
mary PCI. However, those patients were few in the present study (n ¼ 9).
Because they were converted from ACS to SAP at CABG, they were in-
cluded in the SAP group in the present study. The other patients with
ACS underwent early CABG. Our CABG strategy for ACS, including
STEMI, non-STEMI, and UAP, is shown in Figure E1.
The institutional review board approved the present retrospective study
and waived the need for written consent. We compared the preoperative,
intraoperative, and postoperative variables between the patients with
ACS and SAP. Multivariate logistic regression analysis was performed to
determine the significant predictors of operative death andmajor complica-
tions. The long-term outcomes were compared between the 2 groups. All
data were collected prospectively and reviewed retrospectively.
The primary endpoint of the present study was early all-cause mortality.
The secondary endpoints were (1) earlymorbidity, including re-exploration
because of bleeding, low output syndrome, perioperative myocardial in-
farction, severe ventricular arrhythmia, requirement of hemodialysis,
stroke, or mediastinitis; (2) long-term all-cause mortality, excluding early
deaths; (3) late cardiac death; and (4) late major adverse cardiac and cere-
brovascular events (MACCE).
Surgery
Our strategy for isolated CABG was directed at achieving complete
myocardial revascularization with an off-pump technique, whenever feasi-
ble. Complete revascularization was defined as ‘‘traditional’’ complete-
ness, indicating that all diseased arterial systems (stenosis >50%)
received at least 1 graft. The off-pump CABG technique has been previ-
ously described.10 We bypassed all significantly diseased coronary arteries
(stenosis 50%) that were greater than 1 mm in diameter. If necessary,
concomitant extensive reconstruction (length, 4.0 cm) with or without
endarterectomy was performed in patients with a diffusely diseased left an-
terior descending artery.11 Deep pericardial stay sutures were not used, and
a commercially available heart positioner and stabilizer were applied in all1578 The Journal of Thoracic and Cardiovascular Surcases. Cardiopulmonary bypass with or without cardiac arrest was used in
patients who were not suitable for the off-pump technique, including pa-
tients with severely impaired left ventricular function or intramyocardial
coronary arteries.
Bypass grafts were prepared after heparinization (300 IU/kg). Arterial
grafts (internal thoracic artery [ITA], radial artery, and gastroepiploic ar-
tery) were harvested in a skeletonized fashion. Anastomoses between the
coronary arteries and grafts were performed with 8-0 polypropylene run-
ning sutures using the parachute technique.
We routinely prescribed low-dose aspirin for all postoperative patients,
continued indefinitely. Warfarin (maintained with a target international
normalized ratio of 2.0) was administered for 3 months for patients with
saphenous vein grafts, in addition to low-dose aspirin.
Follow-up was achieved by outpatient office visits, direct communica-
tion with the patient or family, and/or reports from the family physicians.
The last follow-up examination was completed in all patients during
a 1-month closing interval ending in December 2011.
Definitions
UAP was defined as chest pain at rest that was of new onset or that was
increasing in frequency and severity. SAP was defined as chest pain on ex-
ertion that was relieved by rest or medication. Left main coronary artery
disease was defined as the presence of 50% or greater stenosis on any an-
giographic view, according to the Society of Thoracic Surgeons database.
Operative death was defined as death within the same hospitalization or
within 30days of surgery. Cardiacdeath included all deaths from any cardiac
cause (acute myocardial infarction, heart failure, or arrhythmia) and sudden
unexplained deaths. Low-output syndrome was defined as the need for
adrenaline, more than 5 mg/kg/min dopamine or dobutamine, or intra-
aortic balloon pumping. Perioperative myocardial infarction was defined
as newQwaves on the electrocardiogramor a peak creatine kinase-MB level
5 times or more the upper limit of normal (25 IU/L). Respiratory failurewas
defined as a requirement for prolonged ventilation (>48 hours) or the occur-
rence of pneumonia. Postoperative stroke was defined as the occurrence of
a new stroke confirmed by computed tomography. In patients with preoper-
ative stroke, postoperative stroke was defined as a worsening of the neuro-
logic deficit with new radiologic findings. MACCE was defined as death
from any cause, stroke, myocardial infarction, or repeat revascularization.
Statistical Analysis
All statistical analyses were performed using the StatView, version 5.0,
software package or the SAS program for Windows, release 9.2 (SAS In-
stitute, Cary, NC). Continuous variables are reported as the mean  stan-
dard deviation. Continuous variables were compared using the Student t
test, and discrete variables were compared using the chi-square or Fischer
exact test.
Univariate and multivariate logistic regression analyses were performed
to determine the significant predictors of operative death and major mor-
bidity. The variables used for univariate analysis were the clinical variables
listed in Table 1, in addition to ACS and SAP and bilateral ITA use. Vari-
ables with P<.1 on univariate analyses were included in the multivariate
model.
Actuarial event-free survival curves were estimated using the Kaplan-
Meier method. The log-rank test was used to assess the differences in sur-
vival between the 2 groups.
Univariate and multivariate Cox proportional hazard analyses were per-
formed to investigate the significant predictors of late mortality, late car-
diac mortality, and late MACCE. The variables used for univariate
analysis were the clinical variables listed in Table 1 plus ACS, SAP, and
bilateral ITA use. Variables with P< .1 on univariate analyses were in-
cluded in the multivariate model.
A propensity score of having ACS was calculated for each patient using
a logistic regression model that included all the preoperative variables
listed in Table 1. Patients were matched 1 to 1 by the propensity scoresgery c June 2013
TABLE 1. Preoperative patient characteristics
Characteristic
Nonmatched pairs Propensity-matched pairs
ACS (n ¼ 382) SAP (n ¼ 851) P value ACS (n ¼ 342) SAP (n ¼ 342) P value
Age (y) 69.8  9.7 67.1  10.7 <.0001 69.2  9.7 68.8  9.2 .5756
Female gender 104 (27.2) 133 (15.6) <.0001 78 (22.8) 86 (25.1) .5307
BSA (m2) 1.6  0.2 1.7  0.2 .0046 1.6  0.2 1.6  0.2 .9206
EF (%) 55.7  12.3 56.5  11.2 .2579 56.1  12.2 55.7  11.9 .6366
Prior MI 147 (38.5) 404 (47.5) .0040 141 (41.2) 146 (42.7) .7566
Diseased vessel 2.7  0.5 2.8  0.5 .1539 2.8  0.5 2.8  0.5 .7433
Left main disease 178 (46.6) 245 (28.8) <.0001 141 (41.2) 133 (38.9) .5849
Previous PCI 104 (27.2) 249 (29.3) .5075 99 (28.9) 105 (30.7) .6760
CHF 51 (13.4) 102 (12.0) .5627 44 (12.9) 47 (13.7) .8218
Hypertension 271 (70.9) 569 (66.9) .1752 244 (71.3) 239 (69.9) .7371
Diabetes mellitus 164 (42.9) 415 (48.8) .0663 151 (44.2) 149 (43.6) .9386
Hyperlipidemia 243 (63.6) 538 (63.2) .9454 221 (64.6) 221 (64.6) >.9999
Smoking 220 (57.6) 514 (60.4) .3864 204 (59.6) 207 (60.5) .8759
PVD 21 (5.5) 78 (9.2) .0376 20 (5.8) 26 (7.6) .4453
Previous stroke 41 (10.7) 89 (10.5) .9641 37 (10.8) 39 (11.4) .9032
Creatinine (mg/dL) 1.2  1.6 1.2  1.4 .8263 1.2  1.6 1.2  1.5 .7643
COPD 16 (4.2) 29 (3.4) .6087 14 (4.1) 10 (2.9) .5330
Atrial fibrillation 18 (4.7) 41 (4.8) >.9999 17 (5.0) 17 (4.9) >.9999
Data presented as mean  standard deviation or numbers (percentages). ACS, Acute coronary syndrome; BSA, body surface area; CHF, congestive heart failure; COPD, chronic
obstructive pulmonary disease; EF, ejection fraction;MI, myocardial infarction; PCI, percutaneous coronary intervention; PVD, peripheral vascular disease; SAP, stable angina
pectoris.
Fukui et al Acquired Cardiovascular Diseaseusing the greedy matching techniques. Outcomes of interest between the
matched groups were compared using the paired t test for continuous vari-
ables and the McNemar test for discrete variables.A
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DRESULTS
Preoperative Characteristics and Intraoperative and
Early Postoperative Outcomes
The preoperative characteristics of the ACS and SAP
groups are listed in Table 1. The patients with ACS wereTABLE 2. Operative and postoperative patient data
Variable
Nonmatched pairs
ACS (n ¼ 382) SAP (n ¼ 851)
Anastomoses 4.0  1.2 4.2  1.2
ITA use 381 (99.7) 848 (99.6)
Bilateral ITA use 338 (88.5) 754 (88.6)
Extensive reconstruction of LAD 71 (18.6) 211 (24.8)
Off-pump procedure 373 (97.6) 819 (96.2)
Operation time (min) 264.7  62.3 282.2  61.7
Transfusion 177 (46.3) 230 (27.0)
Intubation (h) 11.8  20.3 8.0  8.5
ICU stay (d) 2.6  12.5 1.3  1.1
Operative death 10 (2.6) 1 (0.1)
Re-exploration due to bleeding 6 (1.6) 8 (0.9)
Low output syndrome 12 (3.1) 10 (1.2)
Perioperative MI 6 (1.6) 6 (0.7)
Severe ventricular arrhythmia 3 (0.8) 6 (0.7)
Required hemodialysis 11 (2.9) 9 (1.1)
Stroke 7 (1.8) 10 (1.2)
Mediastinitis 4 (1.0) 7 (0.8)
Data presented as mean standard deviation or numbers (percentages). ACS, Acute corona
descending artery; MI, myocardial infarction; SAP, stable angina pectoris.
The Journal of Thoracic and Carolder, were more likely to be women, had a smaller body
surface area, were more likely to have left main coronary ar-
tery disease, were less likely to have previous myocardial
infarction, and were less likely to have peripheral vascular
disease than those with SAP.
The intraoperative and early postoperative outcomes of
both groups are listed in Table 2. The number of anastomo-
ses per patient was lower in the ACS group than in the SAP
group. No difference was seen in the frequency of ITAPropensity-matched pairs
P value ACS (n ¼ 342) SAP (n ¼ 342) P value
.0292 4.1  1.3 4.2  1.3 .3186
>.9999 341 (99.7) 341 (99.7) >.9999
>.9999 306 (89.5) 304 (88.9% .9020
.0170 69 (20.2) 77 (22.5) .5136
.8018 335 (98.0) 329 (96.2) .2565
<.0001 268.2  62.9 279.2  63.1 .0226
<.0001 149 (43.6) 106 (31.0) .0009
<.0001 11.9  21.3 8.5  10.8 .0093
.0006 2.6  11.7 1.4  1.4 .0511
.0002 9 (2.6) 1 (0.3) .0258
.4792 6 (1.7) 5 (1.5) >.9999
.0018 9 (2.6) 3 (0.9) .1453
.4164 8 (1.5) 2 (0.6) .4474
.2101 2 (0.6) 0 .4789
.0278 9 (2.6) 4 (1.2) .2627
.1372 6 (1.8) 3 (0.9) .5022
.7617 4 (1.2) 4 (1.2) >.9999
ry syndrome; ICU, intensive care unit; ITA, internal thoracic artery; LAD, left anterior
diovascular Surgery c Volume 145, Number 6 1579
TABLE 3. Multivariate logistic regression analysis for operative
death, low output syndrome, and hemodialysis requirement
Outcome OR P value 95% CI
Operative death
Age 1.162 .0063 1.043-1.294
ACS 16.772 .0091 2.015-139.608
EF 0.938 .0204 0.889-0.990
Creatinine 1.320 .0223 1.040-1.676
Low output syndrome
Ejection fraction 0.933 <.0001 0.904-0.963
Bilateral ITA use 0.244 <.0001 0.093-0.641
Required hemodialysis
ACS 2.762 .0346 1.077-7.089
Creatinine 1.253 .0006 1.102-1.425
ACS, Acute coronary syndrome; CI, confidence interval; EF, ejection fraction; ITA,
internal thoracic artery; OR, odds ratio.
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Dgrafts between the 2 groups. Most patients in the present
study received bilateral ITA grafts through an off-pump
procedure.
Postoperatively, the rates of operative death, low output
syndrome, and hemodialysis requirement were significantly
greater in the patients with ACS than in the patients with
SAP. Of the patients with ACS who died, the cause of death
was pneumonia in 5, sepsis in 2, low output syndrome in 1,
thoracic aneurysm rupture in 1, and ischemic colitis in 1. Of
the patients with SAP, 1 patient died of low output
syndrome.
Risk of Operative Death
Univariate analyses identified that age, a smaller body
surface area, ACS, a lower ejection fraction, a history of
congestive heart failure, hyperlipidemia, a greater creati-
nine level, and atrial fibrillation were associated with oper-
ative death. Multivariate analysis (Table 3) revealed that
age, ACS, a lower ejection fraction, and a greater creatinine
level were independent predictors of operative death.
Risk of Postoperative Low Output Syndrome
Univariate analyses identified that age, ACS, a lower
ejection fraction, a history of congestive heart failure, hy-
perlipidemia, a greater creatinine level, and the use of bilat-
eral ITA were associated with the development of low
output syndrome. Multivariate analysis (Table 3) revealed
that a lower ejection fraction and the use of bilateral ITA
were independent predictors of low output syndrome.
ACS was not identified as an independent predictor of
low output syndrome (odds ratio, 1.839; 95% confidence
interval, 0.518-6.533; P ¼ .3462).
Risk of Postoperative Hemodialysis Requirement
Univariate analyses identified that age, ACS, a lower
ejection fraction, a history of congestive heart failure, pe-
ripheral vascular disease, and a greater creatinine level1580 The Journal of Thoracic and Cardiovascular Surwere associated with a hemodialysis requirement. Multivar-
iate analysis (Table 3) revealed that ACS and greater creat-
inine level were independent predictors of a hemodialysis
requirement.
Propensity Score–Matched Pairs Analysis
The preoperative and perioperative data of the
propensity-matched patients are listed in Tables 1 and 2, re-
spectively. These matched pairs were well balanced for all
known covariates (Table 1). The operative death rate was
significantly greater for patients with ACS than for patients
with SAP. However, no difference was found in the
incidence of postoperative complications between the 2
groups.
Long-Term Postoperative Outcomes
Follow-up was complete for 1219 (98.9%) of 1233 pa-
tients. During the follow-up period (44.1  24.6 months),
36 patients with ACS died and 53 patients with SAP died
(excluding operative deaths). Of the 1222 hospital survi-
vors, the actuarial survival at 7 years was 85.4%  2.5%
for patients with ACS and 87.7%  2.0% for patients
with SAP (Figure 1, A). There were 8 cardiac deaths in pa-
tients with ACS and 18 in patients with SAP. Freedom from
cardiac death at 7 years was 97.4%  0.9% for patients
with ACS and 96.5%  0.9% for patients with SAP
(Figure 1, B). Repeat revascularization was performed in
19 patients with ACS and 58 with SAP. Strokewas observed
in 6 patients with ACS and 8 with SAP. Acute myocardial
infarction occurred in 1 patient with ACS and 3 with SAP.
Freedom from MACCE at 7 years was 78.0%  2.9%
for those with ACS and 78.1%  2.3% for those with
SAP (Figure 1, C).
Risk of Late Mortality
Univariate analyses identified that age, a smaller body
surface area, a lower ejection fraction, number of diseased
vessels, left main disease, a greater creatinine level, and
atrial fibrillation were associated with late mortality. Multi-
variate analysis (Table 4) revealed that age, a smaller body
surface area, a lower ejection fraction, and a greater creati-
nine level were independent predictors of late mortality.
ACS was not identified as an independent predictor of late
mortality (hazard ratio, 0.712; 95% confidence interval,
0.466-1.088; P ¼ .1166).
Risk of Late Cardiac Death
Univariate analyses identified that female gender,
a smaller body surface area, a lower ejection fraction, pre-
vious PCI, smoking, and a greater creatinine level were as-
sociated with late cardiac death. Multivariate analysis
(Table 4) revealed that a smaller body surface area, a lower
ejection fraction, previous PCI, and a greater creatinine
level were independent predictors of late cardiac death.gery c June 2013
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FIGURE 1. A, Kaplan-Meier event-free survival analysis for all-cause
death. B, Kaplan-Meier event-free survival analysis for cardiac death. C,
Kaplan-Meier event-free survival analysis for major adverse cardiac and ce-
rebrovascular events (death from any cause, stroke, myocardial infarction,
or repeat revascularization).ACS, Acute coronary syndrome; SAP, stable an-
gina pectoris; MACCE, major adverse cardiac and cerebrovascular events.
TABLE 4. Multivariate Cox proportional hazard analysis for late
mortality
Outcome HR P value 95% CI
Late mortality
Age 1.063 <.0001 1.031-1.095
BSA 0.166 .0007 0.058-0.470
EF 0.967 <.0001 0.952-0.983
Creatinine 1.198 <.0001 1.097-1.310
Late cardiac mortality
BSA 0.127 .0224 0.022-0.746
Ejection fraction 0.964 .0141 0.936-0.993
Previous PCI 3.471 .0453 1.027-11.737
Creatinine 1.254 .0004 1.107-1.419
Late MACCE
BSA 0.444 .0496 0.197-0.999
EF 0.981 .0017 0.969-0.993
Creatinine 1.096 .0163 1.017-1.182
BSA, Body surface area; CI, confidence interval; EF, ejection fraction;HR, hazard ra-
tio; MACCE, major adverse cardiac and cerebrovascular events; PCI, percutaneous
coronary intervention.
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DACS was not identified as an independent predictor of late
cardiac death (hazard ratio, 1.082; 95% confidence interval,
0.470-2.490; P ¼ .8532).The Journal of Thoracic and CarRisk of Late MACCE
Univariate analyses identified that age, a smaller body
surface area, a lower ejection fraction, number of diseased
vessels, and a greater creatinine level were associated
with late MACCE. Multivariate analysis (Table 4) revealed
that a smaller body surface area, a lower ejection fraction,
and a greater creatinine level were independent predictors
of late MACCE. ACS was not identified as an independent
predictor of late MACCE (hazard ratio, 0.945; 95% confi-
dence interval, 0.690-1.296; P ¼ .7276).DISCUSSION
In the present study, ACS was identified as an indepen-
dent predictor of operative death. Among hospital survi-
vors, however, no difference was seen in long-term
mortality between patients with ACS versus those with
SAP.
Recent advances in technology have led to an increase in
the proportion of patients with ACS undergoing PCI. Ben-
Gal and colleagues12 compared the early and mid-term out-
comes of patients with ACS after treatment with PCI or
CABG in a propensity-matched study. They found that al-
though PCI was associated with lower rates of periproce-
dural stroke, major bleeding, and acute renal injury,
CABGwas associated with greater freedom from both early
and late recurrent ischemia requiring repeat revasculariza-
tion procedures. The survival at 1 month and 1 year were
comparable between the groups. The selection of the opti-
mal revascularization modality for patients with ACS de-
pends on the patient characteristics and lesion severity.
CABG is still appropriate for patients with disease refrac-
tory to medical therapy and when PCI is not suitable or
possible.diovascular Surgery c Volume 145, Number 6 1581
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DA review study by Kaiser and colleagues13 reported that
the mean operative mortality rate in CABG patients with
UAP was 3.7% (range, 1.2-8.8%). In the present study,
the operative death rate was significantly greater in patients
with ACS than with SAP (2.6% vs 0.1%). Bonacchi and
colleagues9 did not find any difference in the operative mor-
tality rate between patients undergoing urgent and elective
CABG, but both groups in their study had high mortality
rates (7% vs 5.3%). They reported that 68% of hospital
deaths had a cardiac cause. Bjessmo et al6 found almost
85% of early deaths had a cardiac cause and speculated
that the high incidence of cardiac death was related to peri-
operative myocardial protection methods. Onorati and col-
leagues14 evaluated myocardial protection methods in
patients with ACS and found that off-pump CABG and
on-pump CABGwith antegrade and retrograde blood cardi-
oplegia resulted in less elevation of troponin I levels than
on-pump CABG with isolated antegrade cardioplegia.
They suggested that patients with ACS who underwent
off-pump CABG seemed to have better outcomes compared
with patients who received simple myocardial protection
techniques during cardiopulmonary bypass. Recently,
Ben-Gal and colleagues15 found that off-pump CABG
was associated with lower rates of bleeding and non–
Q-wave myocardial infarction than on-pump CABG in
patients with ACS. Rastan and colleagues7 reported that
beating heart coronary artery grafting was associated with
an improved hospital outcome compared with cardioplegic
cardiac arrest in patients with ACS. In the present study, the
major cause of operative death in patients with ACSwas not
low output syndrome (1 of 10 patients). We believe that 1 of
reasons for this might be because most operations were per-
formed using the off-pump technique. In patients with on-
going myocardial ischemia, off-pump CABG might
reduce the myocardial damage by avoidance of reperfusion
injury.7,15
The use of arterial grafts for myocardial revascularization
has been widely accepted because of the clinical advantage
of using the left ITA as a bypass conduit.16 The use of bilat-
eral ITA grafts has been shown to provide survival and
economic benefits compared with the use of a single ITA
graft.17 Bonacchi and colleagues9,18 demonstrated the
safety and effectiveness of using bilateral ITA grafts in
patients with ACS. Furthermore, they showed the
superiority of bilateral ITA grafts compared with single
ITA grafts in mid-term and event-free survival in patients
with ACS.18 However, bilateral ITA grafts are not routinely
used on a widespread basis, even in elective patients, for
multiple reasons, including increased operative difficulty,
increased operating time, and the risk of wound complica-
tions.19 In the present study, we used bilateral ITA grafts
for most patients. Harvesting the bilateral ITA takes longer
than the time needed for single ITA. Accordingly, it might
be inappropriate to use bilateral ITA for patients with1582 The Journal of Thoracic and Cardiovascular SurACS because it will delay reperfusion in the culprit lesion.
However, in the present study, the use of bilateral ITA was
not the independent risk factor for operative death (odds ra-
tio, 0.339; 95% confidence interval, 0.089-1.295;
P¼ .1137) or the requirement for hemodialysis (odds ratio,
0.727; 95% confidence interval, 0.210-2.0514; P ¼ .6150)
on univariate analysis. However, the use of bilateral ITA
was protective for low output syndrome on univariate anal-
ysis (odds ratio, 0.267; 95% confidence interval, 0.107-
0.666; P ¼ .0046) and multivariate analysis (odds ratio,
0.244; 95% confidence interval, 0.904-0.963; P ¼ .0042).
Bonacchi and colleagues20 stated that in emergent/urgent
myocardial revascularization with careful patient manage-
ment, it is possible to spend a few minutes more to harvest
both ITAs using a skeletonized technique. This is because of
the important early and long-term advantages of this con-
duit, such as early improved flow/reperfusion and freedom
from late atherosclerotic disease in patients with UAP.20
We believe that bilateral ITA grafts should be used
even in patients with ACS because of the long-term
survival advantage as long as they are harvested in appropri-
ate time.
In patients undergoing PCI, long-term outcome compar-
isons between patients with ACS and SAP have had con-
flicting results. In the Lescol Intervention Prevention
Study, the long-term risks of UAP and SAP after PCI
were similar in patients with ACS and SAP.21 In a subanal-
ysis of the Arterial Revascularization Therapies Study, no
significant differences were found in the rates of major ad-
verse cardiac events at 1 year between patients with ACS
and SAP.22 However, Naidu and colleagues23 reported
a greater rate of death and of combined death and myocar-
dial infarction for patients with ACS than SAP. In patients
with ACS, the role of the global atherosclerotic burden
and disease progression after PCI in arteries not undergoing
intervention should be considered.23 CABG provides revas-
cularization of most of the epicardial vessels, including the
culprit lesion. Successful CABG might, therefore, reduce
the likelihood of future ischemic events in patients with
ACS. In the present study, no differences were found in
the rates of survival or MACCE between patients with
ACS and SAP.
In patients with ACS, the urgency for surgery was consid-
ered 1 of the risk factors after CABG.24 The European
guideline suggests that the benefit from CABG is greatest
when patients can undergo surgery after several days of sta-
bilization.25 Conversion from ACS to SAP before CABG
would be 1 of the options if patients had stable hemody-
namic condition. In the present study, 9 patients were con-
verted from ACS to SAP because of previous PCI. All had
hemodynamic stability and favorable coronary anatomy
and resulted in no complications after elective CABG.
However, patients with unfavorable anatomy for PCI,
PCI failure, diffuse coronary artery disease, hemodynamicgery c June 2013
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Dinstability, or impaired left ventricular dysfunction should
be considered to perform early CABG. We performed early
CABG for those patients with ACS. With this strategy, 10
operative deaths occurred in patients with ACS. All of
them had required an emergent operation owing to ongoing
ischemia and were not suitable for PCI because of unfavor-
able anatomy. They had relatively high risk scores as fol-
lows: the European System for Cardiac Operative Risk
Evaluation II scorewas 10.1 12.2, the Society of Thoracic
Surgeons predicted risk score was 10.2 10.2, and Synergy
between PCI with Taxus and Cardiac Surgery) score was
24.0  10.2. It was difficult to determine whether these
high-risk patients could have had better outcomes by wait-
ing for conversion from ACS to SAP.
Study Limitations
Our study had the following limitations. This was a retro-
spective observational study. The treatment and treatment
timing varied according to the practices of the individual
physicians and surgeons. Also, the number of patients and
the follow-up period of 7 years might not be sufficient to
provide definitive results.
CONCLUSIONS
ACS is an independent predictor of early mortality in pa-
tients undergoing CABG. However, the long-term out-
comes after surgery were similar between patients with
ACS and SAP, once patients had survived the early postop-
erative period.
The authors thank Ko Bando, MD, for his extensive review and
valuable comments.
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FIGURE E1. Our strategy of coronary artery bypass grafting (CABG) for acute coronary syndrome (ACS). STEMI, ST-segment elevation myocardial in-
farction; NSTEMI, non–STEMI; UAP, unstable angina pectoris; PCI, percutaneous coronary intervention.
TABLE E1. Preoperative characteristics of study patients and
patients with STEMI
Variable
Study patients
(n ¼ 1233)
Patients with STEMI
(n ¼ 70)
P
value
Age 68.0  10.4 69.3  11.1 .2901
Female gender 237 (19.2) 12 (17.1) .7840
BSA (m2) 1.7  0.2 1.6  0.2 .3667
EF (%) 56.3  11.5 44.1  12.4 <.0001
Previous MI 551 (44.7) 23 (32.9) .0694
Diseased vessel 2.8  0.5 2.8  0.4 .3518
Left main disease 423 (34.3) 27 (38.6) .5479
Previous PCI 353 (28.6) 26 (37.1) .1644
CHF 153 (12.4) 27 (38.6) <.0001
Hypertension 840 (68.1) 41 (58.6) .1259
Diabetes mellitus 579 (47.0) 34 (48.6) .8867
Hyperlipidemia 781 (63.3) 33 (47.1) .0094
Smoking 734 (59.5) 39 (55.7) .6120
PVD 99 (8.0) 6 (8.6) >.9999
Previous stroke 130 (10.5) 10 (14.3) .4323
Creatinine (mg/dL) 1.2  1.5 1.0  0.5 .2836
COPD 45 (3.6) 2 (2.9) >.9999
Atrial fibrillation 59 (4.8) 5 (7.1) .3856
Data presented as mean  standard deviation or numbers (percentages). BSA, Body
surface area; CHF, congestive heart failure; COPD, chronic obstructive pulmonary
disease; EF, ejection fraction;MI, myocardial infarction; PCI, percutaneous coronary
intervention; PVD, peripheral vascular disease; STEMI, ST-segment elevation myo-
cardial infarction.
TABLE E2. Operative and postoperative data of study patients and
patients with STEMI
Variable
Study patients
(n ¼ 1233)
Patients with
STEMI (n ¼ 70)
P
value
Anastomoses 4.1  1.2 4.0  1.2 .3942
ITA use 1229 (99.7) 69 (98.6) .2416
Bilateral ITA use 1092 (88.6) 55 (78.6) .0205
Extensive reconstruction
of LAD
282 (22.9) 14 (20.0) .6809
Off-pump procedure 1192 (96.7) 64 (91.4) .0499
Operation time (min) 276.8  62.4 261.9  50.6 .0495
Transfusion 407 (33.0) 38 (54.3) .0004
Intubation (h) 9.2  13.5 34.2  105.4 <.0001
ICU stay (d) 1.7  6.3 5.5  16.9 <.0001
Operative death 11 (0.9) 0 >.9999
Re-exploration due to
bleeding
14 (1.1) 1 (1.4) .5652
Low output syndrome 22 (1.8) 6 (8.6) .0007
Perioperative MI 12 (1.0) 0 >.9999
Severe ventricular arrhythmia 9 (0.7) 5 (7.1) .0008
Required hemodialysis 20 (1.6) 2 (2.9) .3330
Stroke 17 (1.4) 4 (5.7) .0228
Mediastinitis 11 (0.9) 1 (1.4) .4863
Data presented as mean  standard deviation or numbers (percentages). ICU, Inten-
sive care unit; ITA, internal thoracic artery; LAD, left anterior descending artery;MI,
myocardial infarction; STEMI, ST-segment elevation myocardial infarction.
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